The biopharmaceutical industry in India is experiencing remarkable growth, driven by the rapid expansion of biosimilars, vaccines, and advanced therapeutics. As one of the premier platforms dedicated to bioprocessing innovation in the region, BPI India 2026 will bring together industry leaders, scientists, manufacturers, and solution providers to discuss the future of biologics manufacturing and downstream processing. VDO Biotech is excited to announce our participation in this important event and looks forward to connecting with partners and innovators shaping the next generation of biopharmaceuticals.

Visit VDO Biotech at Booth A22

At Booth A22, VDO Biotech will showcase our comprehensive Separation and Purification Solutions for Bioprocessing, designed to support critical applications including:

• Antibody Purification

• Recombinant Protein Purification

• Biosimilars Manufacturing

• Vaccine Purification

• Cell & Gene Therapy

Our portfolio covers the entire downstream purification workflow, featuring:

Ion Exchange Resins

VDX HQ, VDX HS, VDX XQ, VDX XS, SP Focurose FF/HF/HPR, Q Focurose FF/HF/HPR, DEAE Focurose FF/HF and CM Focurose FF.

Affinity Resins

VDX NTA Ni ultra, VDX VH3, arProtein A Focurose HR, Protein G Focurose 4FF, and Ni Focurose FF (IDA/TED/IMAC).

Multimodal Resins

VDX MMA ultra and VDX Core A.

Size Exclusion Resins

Focurose 4FF, Focurose 6FF and Focurose G25+.

Beyond Traditional Resins: VDX Chromatography Resins

Our flagship VDX Chromatography Resin platform is engineered to overcome the most challenging purification bottlenecks in modern bioprocessing.

Whether you are struggling with:

• Low aggregate removal

• High HCP or endotoxin residues

• Weak binding of tagged proteins

• Poor separation of closely related proteins

VDX solutions are designed to help simplify process development, improve product purity, and accelerate your path from laboratory research to commercial manufacturing.

About VDO Biotech

Founded in 2014, VDO Biotech is an innovator in materials science and life science. With over 18,000 m² of R&D and manufacturing facilities and a team where 30% of employees are dedicated to R&D, we combine scientific expertise with advanced manufacturing capabilities to deliver reliable technologies and scalable solutions.

Our product portfolio includes advanced diagnostic microsphere materials, biomolecule purification solutions, nanoparticle analysis platforms, and clinical reagents, empowering innovation across clinical diagnostics, biopharmaceutical development, and life science research.

Today, VDO Biotech serves customers in more than 50 countries worldwide, earning the trust of researchers, diagnostic companies, and biopharmaceutical manufacturers through high-quality products and dedicated technical support.

Partnering Locally to Better Serve India

To provide faster technical support and closer collaboration with customers in India, VDO Biotech is proud to work with Viyoni Labs Private Limited, our exclusive partner for chromatography resins in India.

Together, we are committed to delivering high-performance purification solutions, local technical expertise, and responsive customer support to biopharmaceutical companies across the region.

We warmly invite biopharmaceutical companies, CDMOs, researchers, and industry partners to visit Booth A22 to discuss your downstream purification challenges and explore new opportunities for collaboration.

Let's Connect at BPI India 2026

📅 BPI India 2026

📍 Hyderabad, India

📍 Booth A22

To schedule a meeting with our team during the event, please contact us in advance. We look forward to exchanging ideas, exploring new opportunities, and building long-term partnerships for mutual success.

See you at Booth A22!